1
|
Amini P, Okeme JO. Tear Fluid as a Matrix for Biomonitoring Environmental and Chemical Exposures. Curr Environ Health Rep 2024; 11:340-355. [PMID: 38967858 DOI: 10.1007/s40572-024-00454-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/10/2024] [Indexed: 07/06/2024]
Abstract
PURPOSE Exposures to hazardous chemicals have been linked to many detrimental health effects and it is therefore critical to have effective biomonitoring methods to better evaluate key environmental exposures that increase the risk of chronic disease and death. Traditional biomonitoring utilizing blood and urine is limited due to the specialized skills and invasiveness of collecting these fluid samples. This systematic review focuses on tear fluid, which is largely under-researched, as a promising complementary matrix to the traditional fluids used for biomonitoring. The objective is to evaluate the practicability of using human tear fluid for biomonitoring environmental exposures, highlighting potential pitfalls and opportunities. RECENT FINDING Tear fluid biomonitoring represents a promising method for assessing exposures because it can be collected with minimal invasiveness and tears contain exposure markers from both the external and internal environments. Tear fluid uniquely interfaces with the external environment at the air-tear interface, providing a surface for airborne chemicals to diffuse into the ocular environment and interact with biomolecules. Tear fluid also contains molecules from the internal environment that have travelled from the blood to tears by crossing the blood-tear barrier. This review demonstrates that tear fluid can be used to identify hazardous chemicals from the external environment and differentiate exposure groups.
Collapse
Affiliation(s)
- Parshawn Amini
- Department of Chemistry & Chemical Biology, McMaster University, Hamilton, ON, Ontario, L8S 4L8, Canada
| | - Joseph O Okeme
- Department of Chemistry & Chemical Biology, McMaster University, Hamilton, ON, Ontario, L8S 4L8, Canada.
| |
Collapse
|
2
|
Souza GS, Freitas IMM, Souza JC, Miraglia SM, Paccola CC. Transgenerational effects of maternal exposure to nicotine on structures of pituitary-gonadal axis of rats. Toxicol Appl Pharmacol 2023; 468:116525. [PMID: 37076090 DOI: 10.1016/j.taap.2023.116525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2022] [Revised: 04/10/2023] [Accepted: 04/14/2023] [Indexed: 04/21/2023]
Abstract
Smoking can lead to several diseases and cause a reduction in fertility in men and women. Among the various components of cigarettes harmful during pregnancy, nicotine stands out. It can cause a reduction in placental blood flow, compromising the development of the baby with neurological, reproductive and endocrine consequences. Thus, we aimed to evaluate the effects of nicotine on the pituitary-gonadal axis of rats exposed during pregnancy and breastfeeding (1st generation - F1), and whether the possible damage observed would reach the 2nd generation (F2). Pregnant Wistar rats received 2 mg/kg/day of nicotine throughout the entire gestation and lactation. Part of the offspring was evaluated on the first neonatal day (F1) for macroscopic, histopathological and immunohistochemical analyses of brain and gonads. Another part of the offspring was kept until 90 days-old for mating and obtainment of progenies that had the same parameters evaluated at the end of pregnancy (F2). The occurrence of malformations was more frequent and diversified in nicotine-exposed F2. Brain alterations, including reduced size and changes in cell proliferation and death, were seen in both generations of nicotine-exposed rats. Male and female gonads of F1 exposed rats were also affected. The F2 rats showed reduced cellular proliferation and increased cell death on the pituitary and ovaries, besides increased anogenital distance in females. The number of mast cells was not enough altered to indicate an inflammatory process in brain and gonads. We conclude that prenatal exposure to nicotine causes transgenerational alterations in the structures of pituitary-gonadal axis in rats.
Collapse
Affiliation(s)
- G S Souza
- Developmental Biology Laboratory, Department of Morphology and Genetic, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - I M M Freitas
- Developmental Biology Laboratory, Department of Morphology and Genetic, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - J C Souza
- Developmental Biology Laboratory, Department of Morphology and Genetic, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - S M Miraglia
- Developmental Biology Laboratory, Department of Morphology and Genetic, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - C C Paccola
- Developmental Biology Laboratory, Department of Morphology and Genetic, Federal University of Sao Paulo, Sao Paulo, Brazil.
| |
Collapse
|
3
|
Paccola CC, Souza GS, Freitas IMM, Souza JC, Martins LL, Vendramini V, Miraglia SM. Does maternal exposure to nicotine affect the oocyte quality and reproductive capacity in adult offspring? Toxicol Appl Pharmacol 2021; 426:115638. [PMID: 34242569 DOI: 10.1016/j.taap.2021.115638] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2021] [Revised: 06/05/2021] [Accepted: 07/02/2021] [Indexed: 11/25/2022]
Abstract
Gonadal development begins in the intrauterine phase and females from most species are born with an established oocyte reserve. Exposure to drugs during gestation can compromise the offspring health, also affecting the gametes quality. Nicotine, the main component of cigarettes, is an oxidant agent capable of altering the fertility in men and women. As female gametes are susceptible to oxidative stress, this drug can damage the oolemma and affect oocyte maturation, induce errors during chromosomal segregation and DNA fragmentation. Oocyte mitochondria are particularly susceptible to injuries, contributing to the oocyte quality loss and embryonic development disruption. Thus, considering the high number of women who smoke during pregnancy, while significant events are occurring in the embryo for future fertility of offspring, we seek to verify the quality of the oocytes from adult rats exposed to nicotine during intrauterine phase and breastfeeding. Pregnant Wistar rats received nicotine by osmotic mini-pumps and the female progenies were evaluated in adulthood for oocyte quality (viability, lipid peroxidation, generation of reactive oxygen species and mitochondrial integrity) and reproductive capacity. Embryos (3dpc) and fetuses (20dpc) generated by these rats were also evaluated. The results showed that the dose of 2 mg/kg/day of nicotine through placenta and breast milk does not affect the number of oocytes and the fertility capacity of adult rats. However, it causes some morphological alterations in oocytes, mitochondrial changes, embryonic fragmentation and disruption of fetal development. The malformations in fetuses generated from these gametes can also indicate the occurrence of epigenetic modifications.
Collapse
Affiliation(s)
- C C Paccola
- Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil.
| | - G S Souza
- Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - I M M Freitas
- Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - J C Souza
- Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - L L Martins
- Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - V Vendramini
- Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil
| | - S M Miraglia
- Developmental Biology Laboratory, Department of Morphology and Genetics, Federal University of Sao Paulo, Sao Paulo, Brazil
| |
Collapse
|
4
|
Nicotine Replacement Therapy during Pregnancy and Child Health Outcomes: A Systematic Review. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph18084004. [PMID: 33920348 PMCID: PMC8070414 DOI: 10.3390/ijerph18084004] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/07/2021] [Revised: 04/07/2021] [Accepted: 04/09/2021] [Indexed: 12/20/2022]
Abstract
Tobacco smoking in pregnancy is a worldwide public health problem. A majority of pregnant smokers need assistance to stop smoking. Most scientific societies recommend nicotine replacement therapy (NRT) during pregnancy but this recommendation remains controversial because of the known fetal toxicity of nicotine. The objective of this systematic review was to provide an overview of human studies about child health outcomes associated with NRT use during pregnancy. The electronic databases MEDLINE, the Cochrane Database, Web of Science, and ClinicalTrials.gov were searched from the inception of each database until 26 December 2020. A total of 103 articles were identified through database searching using combination of keywords. Out of 75 screened articles and after removal of duplicates, ten full-text articles were assessed for eligibility and five were included in the qualitative synthesis. NRT prescription seems to be associated with higher risk of infantile colic at 6 months as in case of smoking during pregnancy, and with risk of attention-deficit/hyperactivity disorder. No association between NRT during pregnancy and other infant health disorders or major congenital anomalies has been reported. Well-designed controlled clinical trials with sufficient follows-up are needed to provide more information on the use of NRT or other pharmacotherapies for smoking cessation during pregnancy on post-natal child health outcomes.
Collapse
|
5
|
Berlin I. [Maternal smoking during pregnancy: A risk factor for respiratory disorders in children]. Rev Mal Respir 2018; 35:686-693. [PMID: 29954637 DOI: 10.1016/j.rmr.2017.11.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2017] [Accepted: 11/30/2017] [Indexed: 11/25/2022]
Abstract
Maternal smoking during pregnancy (MSDP) is a well-established risk factor for negative pregnancy outcomes, but its negative effects on the health of the child after birth are less well known by both health professionals and the general public. Large cohort studies over the past 10 years have shown that MSDP is an independent risk factor for several childhood health problems such as e.g. obesity and smoking. A large number of recent studies and 3 meta-analyses demonstrate that MSDP is an independent risk factor of wheezing and asthma of the child exposed in utero to maternal smoking. MSDP is associated with epigenetic toxicities the currently most plausible hypothesis to explain the diversity of its postnatal negative effects. The eradication of MSDP could contribute to the reduction of health problems in the next generation, including the incidence of childhood respiratory disorders.
Collapse
Affiliation(s)
- I Berlin
- Département de pharmacologie, CESP-Inserm 1018, hôpital Pitié-Salpêtrière, faculté de médecine,Sorbonne université, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
| |
Collapse
|
6
|
Mohammadi S, Domeno C, Nerin I, Aznar M, Samper P, Khayatian G, Nerin C. Toxic compounds from tobacco in placenta samples analyzed by UPLC-QTOF-MS. J Pharm Biomed Anal 2017; 145:331-338. [PMID: 28710994 DOI: 10.1016/j.jpba.2017.06.028] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2016] [Revised: 06/13/2017] [Accepted: 06/14/2017] [Indexed: 11/24/2022]
Abstract
Polycyclic aromatic hydrocarbons (PAHs), tobacco-specific nitrosamines (TSNAs) and aromatic amines are carcinogens present in cigarette smoke. These compounds are distributed in the human body and they could be transferred to the foetus during the pregnancy. Placenta is the main barrier to these toxic compounds and its study is the objective of this work. A method based on solid-phase extraction (SPE) with ultra-performance liquid chromatography-tandem quadrupole-time-of-flight mass spectrometry (UPLC-QTOF-MS) has been examined and optimized for the analysis of 9 target analytes (4 tobacco-specific nitrosamines and some of their metabolites, 3 aromatic amines, nicotine and cotinine) in 26 placenta samples from smoking and non-smoking women. Limits of detection (LODs) were in the range of 3-27ng/g of placenta. Nicotine, cotinine, N-nitrosoanatabine (NAT) and 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK) metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) were detected in the placenta samples of smoking woman. Nicotine was detected in 3 out of 8 placentas from smoking women, always below the limit of quantification (88ng/g). This could be expected, as the half-life of nicotine in the body is limited to about 0.5-3h. Cotinine, the main metabolite from nicotine, was detected in all placentas from smoking women at concentrations between 17.2 and 61.8ng/g, reaching the highest values for those women that smoked the highest number of cigarettes. NAT and NNAL were detected in all placentas from smoking women, always below the limit of quantification (40ng/g and 33ng/g respectively).
Collapse
Affiliation(s)
- Somayeh Mohammadi
- Department of Analytical Chemistry, Instituto de Investigación en Ingenieria de Aragon (I3A), University of Zaragoza, Zaragoza, 50018, Spain; Department of Chemistry, Faculty of Science, University of Kurdistan, P.O. Box 416, 66177-15175 Sanandaj, Iran
| | - Celia Domeno
- Department of Analytical Chemistry, Instituto de Investigación en Ingenieria de Aragon (I3A), University of Zaragoza, Zaragoza, 50018, Spain
| | - Isabel Nerin
- Smoking Cessation Unit, Department of Medicine, Psychiatry and Dermatology, Faculty of Medicine, University of Zaragoza, Zaragoza, 50009, Spain
| | - Margarita Aznar
- Department of Analytical Chemistry, Instituto de Investigación en Ingenieria de Aragon (I3A), University of Zaragoza, Zaragoza, 50018, Spain
| | - Pilar Samper
- Department of Pediatrics, Radiology and Physical Medicine, Faculty of Medicine, University of Zaragoza, Zaragoza 50009, Spain
| | - Gholamreza Khayatian
- Department of Chemistry, Faculty of Science, University of Kurdistan, P.O. Box 416, 66177-15175 Sanandaj, Iran
| | - Cristina Nerin
- Department of Analytical Chemistry, Instituto de Investigación en Ingenieria de Aragon (I3A), University of Zaragoza, Zaragoza, 50018, Spain.
| |
Collapse
|